Treatment options in platinum-refractory male germ cell cancers: current standards and future directions
Therapeutic Advances in Medical Oncology
Published online on May 31, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Germ cell cancers (GCCs) represent the most common malignant tumours among men up to the age of 40 years. GCCs are characterised by high cure rates of >99% for localised stage I disease, but even at advanced metastatic stages, 67%–96% of patients can be ...
Germ cell cancers (GCCs) represent the most common malignant tumours among men up to the age of 40 years. GCCs are characterised by high cure rates of >99% for localised stage I disease, but even at advanced metastatic stages, 67%–96% of patients can be ...